Summary
Synopsys, Inc. (SNPS) reported strong revenue growth of 8% for fiscal year 2019, reaching $3.4 billion, driven by its Semiconductor & System Design segment. The company's strategic restructuring and adoption of ASC 606 revenue recognition standards contributed to a significant increase in operating income. Synopsys continues to lead in Electronic Design Automation (EDA) software and semiconductor intellectual property (IP), while also expanding its Software Integrity segment focused on code security and quality. Despite ongoing global economic uncertainties and competitive pressures, Synopsys demonstrated resilience. The company's robust financial performance was supported by consistent revenue growth and effective expense management. Investors can find confidence in Synopsys' market leadership, its diversified product portfolio spanning silicon to software, and its strategic investments in innovation and expansion. The company's commitment to returning value to shareholders is evident through its active stock repurchase program. Overall, the filing indicates a financially sound company with a strong market position and a clear strategy for continued growth.
Financial Highlights
56 data points| Revenue | $3.36B |
| Cost of Revenue | $752.95M |
| Gross Profit | $2.61B |
| R&D Expenses | $1.14B |
| Operating Expenses | $2.09B |
| Operating Income | $520.23M |
| Interest Expense | $11.66M |
| Net Income | $532.37M |
| EPS (Basic) | $3.55 |
| EPS (Diluted) | $3.45 |
| Shares Outstanding (Basic) | 149.87M |
| Shares Outstanding (Diluted) | 154.19M |
Key Highlights
- 1Synopsys reported an 8% increase in revenue, reaching $3.4 billion for fiscal year 2019.
- 2The Semiconductor & System Design segment remains the primary revenue driver, while the Software Integrity segment showed substantial growth (19%).
- 3Operating income saw a significant increase of 44% year-over-year, indicating improved profitability.
- 4The company adopted new revenue recognition standards (ASC 606), which impacted revenue reporting but did not affect cash generated.
- 5Synopsys continued to invest heavily in Research and Development, a key factor in maintaining its technology leadership.
- 6A substantial stock repurchase program of $500 million was in place, with $400 million remaining availability at the end of the fiscal year.
- 7The company maintained effective internal controls and reported an unqualified opinion from its independent registered public accounting firm.